112 related articles for article (PubMed ID: 33649105)
1. The Discovery of a Novel Antimetastatic Bcl3 Inhibitor.
Soukupová J; Bordoni C; Turnham DJ; Yang WW; Seaton G; Gruca A; French R; Lee KY; Varnava A; Piggott L; Clarkson RWE; Westwell AD; Brancale A
Mol Cancer Ther; 2021 May; 20(5):775-786. PubMed ID: 33649105
[TBL] [Abstract][Full Text] [Related]
2. Diverse effects of BCL3 phosphorylation on its modulation of NF-kappaB p52 homodimer binding to DNA.
Bundy DL; McKeithan TW
J Biol Chem; 1997 Dec; 272(52):33132-9. PubMed ID: 9407099
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-627-5p inhibits the proliferation of hepatocellular carcinoma cells by targeting BCL3 transcription coactivator.
Wang J; Chen T; Wang L; Yao B; Sun L; Chen S; Liu Q
Clin Exp Pharmacol Physiol; 2020 Mar; 47(3):485-494. PubMed ID: 31793036
[TBL] [Abstract][Full Text] [Related]
4. Bcl3 Phosphorylation by Akt, Erk2, and IKK Is Required for Its Transcriptional Activity.
Wang VY; Li Y; Kim D; Zhong X; Du Q; Ghassemian M; Ghosh G
Mol Cell; 2017 Aug; 67(3):484-497.e5. PubMed ID: 28689659
[TBL] [Abstract][Full Text] [Related]
5. BCL3 encodes a nuclear protein which can alter the subcellular location of NF-kappa B proteins.
Zhang Q; Didonato JA; Karin M; McKeithan TW
Mol Cell Biol; 1994 Jun; 14(6):3915-26. PubMed ID: 8196632
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-9 regulates NF-kappaB activity through BCL3 gene induction.
Richard M; Louahed J; Demoulin JB; Renauld JC
Blood; 1999 Jun; 93(12):4318-27. PubMed ID: 10361130
[TBL] [Abstract][Full Text] [Related]
7. Expression Of Intracellular Components of the NF-κB Alternative Pathway (NF-κB2, RelB, NIK and Bcl3) is Associated With Clinical Outcome of NSCLC Patients.
Dimitrakopoulos FD; Antonacopoulou AG; Kottorou AE; Panagopoulos N; Kalofonou F; Sampsonas F; Scopa C; Kalofonou M; Koutras A; Makatsoris T; Dougenis D; Papadaki H; Brock M; Kalofonos HP
Sci Rep; 2019 Oct; 9(1):14299. PubMed ID: 31586084
[TBL] [Abstract][Full Text] [Related]
8. Bcl3: a regulator of NF-κB inducible by TWEAK in acute kidney injury with anti-inflammatory and antiapoptotic properties in tubular cells.
Poveda J; Sanz AB; Carrasco S; Ruiz-Ortega M; Cannata-Ortiz P; Sanchez-Niño MD; Ortiz A
Exp Mol Med; 2017 Jul; 49(7):e352. PubMed ID: 28684863
[TBL] [Abstract][Full Text] [Related]
9. Changes in expression induced by Epstein-Barr Virus LMP1-CTAR1: potential role of bcl3.
Edwards RH; Marquitz AR; Raab-Traub N
mBio; 2015 Apr; 6(2):. PubMed ID: 25873381
[TBL] [Abstract][Full Text] [Related]
10. High-level expression of BCL3 differentiates t(2;5)(p23;q35)-positive anaplastic large cell lymphoma from Hodgkin disease.
Nishikori M; Maesako Y; Ueda C; Kurata M; Uchiyama T; Ohno H
Blood; 2003 Apr; 101(7):2789-96. PubMed ID: 12456498
[TBL] [Abstract][Full Text] [Related]
11. BCL3 Reduces the Sterile Inflammatory Response in Pancreatic and Biliary Tissues.
Song L; Wörmann S; Ai J; Neuhöfer P; Lesina M; Diakopoulos KN; Ruess D; Treiber M; Witt H; Bassermann F; Halangk W; Steiner JM; Esposito I; Rosendahl J; Schmid RM; Riemann M; Algül H
Gastroenterology; 2016 Feb; 150(2):499-512.e20. PubMed ID: 26526716
[TBL] [Abstract][Full Text] [Related]
12. Immunoblotting Analysis of Intracellular PD-L1 Levels in Interferon-γ-Treated Ovarian Cancer Cells Stably Transfected with Bcl3 shRNA.
Padmanabhan S; Zou Y; Vancurova I
Methods Mol Biol; 2020; 2108():211-220. PubMed ID: 31939183
[TBL] [Abstract][Full Text] [Related]
13. The proto-oncogene Bcl3 induces immune checkpoint PD-L1 expression, mediating proliferation of ovarian cancer cells.
Zou Y; Uddin MM; Padmanabhan S; Zhu Y; Bu P; Vancura A; Vancurova I
J Biol Chem; 2018 Oct; 293(40):15483-15496. PubMed ID: 30135206
[TBL] [Abstract][Full Text] [Related]
14. Bcl3 prevents acute inflammatory lung injury in mice by restraining emergency granulopoiesis.
Kreisel D; Sugimoto S; Tietjens J; Zhu J; Yamamoto S; Krupnick AS; Carmody RJ; Gelman AE
J Clin Invest; 2011 Jan; 121(1):265-76. PubMed ID: 21157041
[TBL] [Abstract][Full Text] [Related]
15. High expression of BCL3 in human myeloma cells is associated with increased proliferation and inferior prognosis.
Brenne AT; Fagerli UM; Shaughnessy JD; Våtsveen TK; Rø TB; Hella H; Zhan F; Barlogie B; Sundan A; Børset M; Waage A
Eur J Haematol; 2009 May; 82(5):354-63. PubMed ID: 19191868
[TBL] [Abstract][Full Text] [Related]
16. The B-cell-activating factor signalling pathway is associated with Helicobacter pylori independence in gastric mucosa-associated lymphoid tissue lymphoma without t(11;18)(q21;q21).
Kuo SH; Tsai HJ; Lin CW; Yeh KH; Lee HW; Wei MF; Shun CT; Wu MS; Hsu PN; Chen LT; Cheng AL
J Pathol; 2017 Feb; 241(3):420-433. PubMed ID: 27873317
[TBL] [Abstract][Full Text] [Related]
17. Impaired Bcl3 up-regulation leads to enhanced lipopolysaccharide-induced interleukin (IL)-23P19 gene expression in IL-10(-/-) mice.
Mühlbauer M; Chilton PM; Mitchell TC; Jobin C
J Biol Chem; 2008 May; 283(21):14182-9. PubMed ID: 18375954
[TBL] [Abstract][Full Text] [Related]
18. Bcl3 selectively promotes metastasis of ERBB2-driven mammary tumors.
Wakefield A; Soukupova J; Montagne A; Ranger J; French R; Muller WJ; Clarkson RW
Cancer Res; 2013 Jan; 73(2):745-55. PubMed ID: 23149915
[TBL] [Abstract][Full Text] [Related]
19. Bcl3, an IkappaB protein, stimulates activating protein-1 transactivation and cellular proliferation.
Na SY; Choi JE; Kim HJ; Jhun BH; Lee YC; Lee JW
J Biol Chem; 1999 Oct; 274(40):28491-6. PubMed ID: 10497212
[TBL] [Abstract][Full Text] [Related]
20. BCL3 acts as a negative regulator of transcription from the human T-cell leukemia virus type 1 long terminal repeat through interactions with TORC3.
Hishiki T; Ohshima T; Ego T; Shimotohno K
J Biol Chem; 2007 Sep; 282(39):28335-28343. PubMed ID: 17644518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
